Open Access Article
Kazi Zannatul Ferdwushee,
Md Abu Shahid Chowdhury
* and
Siddika Tamanna Islam
Department of Biomedical Engineering, Khulna University of Engineering & Technology, Khulna, 9203, Bangladesh. E-mail: shahid@bme.kuet.ac.bd
First published on 30th May 2026
Surface plasmon resonance (SPR) has been an emerging tool for the recognition of cancer in a label-free manner. However, conventional SPR setups are based on prism coupling, which makes them bulky, hindering their capability to be integrated into compact and portable devices. To overcome these issues, the proposed approach introduces a photonic crystal fiber (PCF) structure with a micro-channel D-shaped, integrated with a gold (Au) coating as the plasmonic substance and titanium dioxide (TiO2) as a dielectric substance. It minimizes the distance of the plasmonic film from the fiber core, thus elevating the sensor performance. In addition, the introduction of TiO2 over the plasmonic film alters the plasmon–analyte interaction, thus increasing the sensitivity. The numerical simulation for the designed sensor is done in COMSOL Multiphysics software through the finite element method (FEM). After optimization, the sensor is numerically evaluated for the identification of six various carcinoma cell types for refractive indices between 1.360 to 1.401. The ultimate achieved amplitude and spectral sensitivities are 717.29 per RIU and 7142.86 nm per RIU, respectively, recorded for MDA-MB-231 and MCF-7 cells. Additionally, the optimized sensor can distinguish a diverse array of biomolecules across the RI span of 1.330 to 1.420, attaining a peak spectral sensitivity of 20
000 nm per RIU for y-polarized light. Moving further, the sensor also delineated excellent figure of merit, resolution, and amplitude sensitivity values of 366 per RIU, 5 × 10−6 RIU, and 1178 per RIU, respectively, within the mentioned RI domain. The measured outcomes show that the designed sensor could be a potential option for the precise identification of various cancer cells.
120 cancer fatalities and 2
041
910 newly discovered carcinoma cases are estimated to occur in the USA by the end of 2025.1–4 The global death toll projection is going up to 16.9 million per year by the year 2045. A significant portion of cancers exhibit no symptoms until later stages, demonstrating the disease's complex and challenging nature, with 70% of cancer fatalities in resource-limited areas resulting from restricted access to early screening and treatment.5 Despite significant advances in conventional cancer detection methods, such as imaging modalities like mammography, MR imaging, computed tomography (CT), positron emission tomography (PET), and biopsies, as well as blood and tissue-based diagnostic evaluation tools like polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA), these mechanisms still endure major drawbacks. These include low specificity, high costs, radiation exposure risk, time-intensive procedures, and dependency on advanced laboratory setup, among others.6 While AI and machine learning have contributed to improved scan accuracy, these technologies still do not provide the kind of non-invasive, real-time, and universal cancer detection needed.7 Taking into consideration the significant constraints that the traditional methods present, it is logical to say that the healthcare system needs quick, inexpensive, and non-invasive diagnostic alternatives. A biosensor could be a probable solution for overcoming the aforementioned limitations due to its sensitive, selective, and time-efficient analysis of biological targets in a user-friendly manner. Present-day biosensors use enzymes and antibodies as biorecognition elements in their detection of cancer biomarkers.8,9 However, the use of enzymes and antibodies results in degradation over time, and subsequently, the sensor performance is affected.
In this context, optical biosensors can hold significant potential in cancer diagnosis owing to their real-time and continuous detection in a highly responsive, selective, affordable, and non-invasive manner. Different optical biosensors also have dependence on labeled techniques, which incorporate electrochemically active probes, fluorescent labeling, and chemiluminescence. Nevertheless, this method can be quite expensive, require a lot of time, and may also disrupt the receptor–analyte interactions.10 To avoid this problem, label-free optical sensors are strongly recommended. Surface plasmon resonance (SPR) biosensors that allow the identification of target substances at very low concentrations without the need for labeling are the most precise optical methods.11,12 The SPR serves as a powerful tool for point-of-care testing of oncogenic biomarkers in a label-free manner with high specificity, sensitivity, fast sensing, and high repeatability, which can also characterize distinct types of carcinomas. The principle behind the SPR biosensor is a shift in the refractive index (RI) in the ambient environment being measured as it relates to the binding of molecules at the surface of the metal. A heterostructured SPR biosensor composed of graphene and MXene (Ti3C2TX), along with a BK7 prism, gold (Au), and aluminum oxide (Al2O3) for the rapid characterization of a well-known cancer-associated marker, carcinoembryonic antigen, was proposed by Khodaie and Heidarzadeh.13 The findings presented a figure of merit (FoM) of 17.52 per RIU and a comparatively enhanced sensitivity of 163.63 deg per RIU. The use of ZnO and TMDC layers in a SPR biosensor by Jiang et al.11 allowed for the identification of distinct carcinoma cells. The proposed biosensor demonstrated the figure of merit and the highest sensitivity values of 124.86 per RIU and 342.14 deg per RIU in terms of detecting blood cancer (Jurkat) cells from healthy cells. Another recent study proposed a BaTiO3 and black phosphorus-based SPR biosensor for the identification of different malignancy biomarkers, where a maximum sensitivity of 417.86 deg per RIU was achieved for breast cancer MCF-7 cells (mammary carcinoma type II).5 On the other hand, the regular prism-coupled SPR setups, which are the basis for sensing technologies, have some drawbacks, such as their large size, high price, and the fact that they are difficult to incorporate into small, portable devices.
In this context, the fiber optic SPR sensors, particularly those utilizing photonic crystal fiber (PCF), so to speak, are the ones bringing the solution to the problems because they are providing miniaturized, flexible, and robust platforms that are, at the same time compatible with in vivo applications and point-of-care diagnostics.14 These enticing features make PCF-based SPR sensors desirable for various biosensing applications, including the detection of blood components,15 heavy metals,16 cancer cells,17 and various other diseases.18 Additionally, the use of AI for geometrical optimization has further enhanced the potential of PCF-based SPR sensors for biomedical applications.19 Among various fiber geometries, including circular, D-shaped, slotted, and bowl-shaped, the D-shaped structure can improve sensor performance by incorporating microchannels.20,21 Numerous researchers have reported a wide variety of D-shaped structures for detecting various analytes. For instance, Divya et al.22 suggested a dual-channel D-shaped PCF-based plasmonic sensor that is able to sense two different analytes simultaneously. The sensor went through an optimization process and then reached the peak amplitude and wavelength sensitivities of 216 per RIU and 10
000 nm per RIU, respectively. Another research work reported by Zhou et al.23 was on a D-shaped PCF-based SPR sensor whose core was an open-ring channel sandwiched between a gold deposition to trigger the plasmonic modes. They showed that analyte placement significantly affects sensitivity. Specifically, when the target analyte was positioned across the outer ring structure, the sensor exhibited an RI finding that lies within the span of 1.2 to 1.34, achieving a peak sensitivity of 2000 nm per RIU. In contrast, when the analyte was placed only on the open channel, the measurable RI span extended from 1.33 to 1.46, and the sensor achieved a peak sensitivity of 5600 nm per RIU. To further improve the performance, Oudenani and Sonne proposed a D-shaped SPR-Based PCF biosensor, which obtained optimum amplitude sensitivity (AS) and wavelength sensitivity (WS) values of 1623.6 per RIU and 12
300 nm per RIU, respectively.24 Moving further, Azadi et al.25 conducted a study wherein a TiO2 dielectric coating was incorporated between a gold plasmonic layer and silica. This structure achieved an optimized AS of 610 per RIU and WS of 14
000 nm per RIU. Moreover, the D-shaped design is efficacious in terms of production as it does not require a complicated setup, as in the case of circular or dual-core PCF, besides being more durable with the Au or TiO2 coatings, and allowing dual-polarization for further deterring of non-target interfering molecules with increased specificity.13
Such facts have prompted this study to go for a D-shaped sensor, which facilitates enhanced performance in distinguishing between different cancer cells and their normal counterparts. The FEM is used to develop and investigate the designed sensor. The study critically examined how the orientation of air spaces, their diameter, and the height of the plasmonic film and overlayers affected the overall effectiveness of the sensor. The influence of the open channel on sensor efficacy is also evaluated. After a thorough study and evaluation, it is concluded that the adjusted sensor structure can identify six different cancer biomarkers from the corresponding healthy cells with maximum AS and WS of 717.29 per RIU and 7142.86 nm per RIU, respectively, for MDA-MB-231 and MCF-7 cells. In addition, the optimized sensor exhibited maximum sensitivities, figure of merit, and resolution values of 20
000 nm per RIU, 1178 per RIU, 366 per RIU, and 5 × 10−6 RIU, respectively, within a wide RI span from 1.330 to 1.420 for y-polarized light. This depicts the sensor's effectiveness in detecting a broad spectrum of bioanalytes with enhanced performance, illustrating its potential to be a strong tool for medical diagnostics.
032 domain, 6136 boundary elements) ensured convergence. Electromagnetic boundary conditions included PML at domain edges, and continuity at material interfaces was implemented. Effective index and confinement loss were extracted from Im(neff) using default solver tolerances. The sensor comprises three main components: a silica (SiO2) substrate featuring circular air holes organized in a hexagonal lattice, a gold (Au) plasmonic layer, and an analyte channel. The cladding region comprises two separate types of air holes, labeled d1 and d2, meticulously designed for superior optical confinement and improved sensing efficacy. The midpoint-to-midpoint gap between neighboring air holes is labeled as pitch (Λ), which determines the modal properties and the guided mode's effective refractive index. A thin coating of TiO2 is embedded between the Au layer and the analyte with a height of tTiO2. After conducting a series of optimization experiments, the structural parameters have been established as pitch = 4 µm, r = 8 µm, d1 = 1.1 µm, d2 = 3 µm, tau = 55 nm, and tTiO2 = 9 nm. tau indicates the height of the Au. The D-shaped arrangement is attained by polishing the fiber surface near the core region, which minimizes the separation between the guided core mode and the Au plasmonic layer. This reduced distance enhances the penetration of the evanescent electric field into the plasmonic coating interface, increasing the modal overlap and improving phase matching with the SPP mode, thereby strengthening SPR excitation and excitation efficiency. The external section of the structure includes an analyte open microchannel with diameter r and a perfectly matched layer (PML) with a thickness of tPML = 5 µm, to mitigate undesirable boundary reflections.
![]() | ||
| Fig. 1 Cross-sectional view of the (a) designed microchannel-type D-shaped sensor, (b) finite element mesh, and (c) experimental setup of the proposed sensor. | ||
Fig. 1c explains a simplified representation of the experimental setting for the sensing approach, including an optical tunable source (OTS) and an optical spectrum analyzer (OSA). The designed sensor is interconnected via a single-mode fiber (SMF). The analyte is placed on the external surface of the sensor, which can be regulated using a pump that passes through the IN/OUT channel. The interaction between the unknown analyte and the sensor surface produces a resonance wavelength shift toward the red or a blue shift, as depicted in Fig. 1c. The OSA can monitor this phenomenon. The unidentified analyte can be determined by investigating the confinement loss on a computer.
![]() | (1) |
| ε∞ | ωD/2π (THz) | γD/2π (THz) | ΓL/2π (THz) | ΩL/2π (THz) | ∇ε |
|---|---|---|---|---|---|
| 5.96730 | 2113.60 | 15.920 | 104.86 | 650.07 | 1.09 |
A thin TiO2 layer is applied as an optical tuning material on the Au coating to modify the local dielectric conditions at the metal–dielectric interface. Its high RI enhances electromagnetic field confinement and improves phase matching with the surface plasmon polariton (SPP) mode, leading to stronger plasmon–analyte interaction and improved RI sensitivity. The subsequent equation determines the relation between the wavelength of TiO2 and its RI.27
![]() | (2) |
Fused silica serves as the foundational substance of the structure in this research. The RI of fused silica changes with the wavelength of light, which causes material dispersion when the fiber is in operation. Therefore, it is fundamental to perform numerical simulations to assess how material dispersion affects the PCF's transmission properties. The Sellmeier equation can determine the RI of fused silica.28
![]() | (3) |
The assessment of sensing performance in PCF-based SPR sensors is significantly dependent on the analysis of confinement loss. The subsequent formula can be used to determine the confinement loss.29
![]() | (4) |
| E1 | E2 | E3 | F1 | F2 | F3 |
|---|---|---|---|---|---|
| 0.6961663 | 0.4079426 | 0.8974794 | 0.0684043 | 0.1162414 | 9.896161 |
The wavelength sensitivity (WS) analysis is a key parameter to assess the sensor's performance. The spectral interrogation approach evaluates sensitivity by observing the shift in resonance wavelength relative to the analyte's RI, mathematically represented as follows.30
![]() | (5) |
The shift in resonance wavelength, which occurs between two successive peaks, is represented by ΔWlpeak and the difference between the two RIs is represented by Δna.
The sensor performance can be evaluated by another significant measurement called amplitude sensitivity (AS). AS depends on variations in oscillatory strength and recognizes the analyte by assessing the changes in confinement loss. The formula for measuring AS is presented as follows:31
![]() | (6) |
The variation in confinement loss between two analytes is ∂α(Wl,na), and confinement loss for the analyte used for the detection is α(Wl,na). Within this context, ∂na denotes the change between the RIs of analytes that are adjacent.
Furthermore, the sensor's figure of merit (FoM) is evaluated to assess the sensing efficacy. The FoM is a quantitative indicator that tells the effectiveness of a sensor, with higher values indicating a higher degree of precision for identifying the RI of a solution. The subsequent equation can be applied to express the FoM.32
![]() | (7) |
Sensor resolution delineates the sensor's capability to perceive deviations in the analyte's RI. This determination is conducted utilizing the following equation:33
![]() | (8) |
Fig. 2e and f show that, for both transverse polarizations (x and y), the plasmonic layer can excite the SPP mode within a certain wavelength range and resonantly interact with the fundamental mode at different frequencies. For x- and y-polarizations, the loss peaks appear at wavelengths of 910 nm and 920 nm, with corresponding confinement losses of 12.95 dB cm−1 and 89.21 dB cm−1, respectively. Overall, y-polarization yields a sharper peak profile and a higher loss peak. This indicates that the plasmonic resonance state is more noticeable in y-polarization and that the SPP mode is excited more effectively.
Since the majority of chemical sensing processes and biochemical interactions usually occur within the RI ranging from 1.33 to 1.42, this range is chosen for investigation.34,35 As the analyte RI fluctuates between 1.33 and 1.42, Fig. 3a and b display the confinement loss characteristics for both transverse polarizations (x and y), which are used to evaluate the sensor's efficiency for multiple analytes. Increasing RI of the analyte induces the resonance peak to redshift toward higher wavelengths, as shown in Fig. 3a and b. A slight change in the RI of the analyte influences the plasmonic mode's RI, which in turn shifts the phase-matching position. When the analyte RI changes from 1.41 to 1.42, the resonance wavelength exhibits maximum shifts of 160 nm and 200 nm for transverse polarizations (x and y), respectively. The optimal WSs achieved at RI = 1.41 of 16
000 nm per RIU and 20
000 nm per RIU for the transverse polarizations (x and y) modes, respectively.
The effectiveness of the sensor is further evaluated by determining AS using the amplitude measurement approach for both transverse polarizations (x and y), as displayed in Fig. 3c and d. The y-polarization mode demonstrates greater performance (AS) than the x-polarization mode, due to a more pronounced loss peak observed in the y-polarization response. The peak ASs of 658 per RIU and 1178 per RIU are measured for the transverse polarizations (x and y) modes, respectively.
The sensor's performance is quantified using the figure of merit (FoM). A higher FoM signifies superior sensor performance. The estimated FoM values for various analyte RIs are presented in Table 3. The designed sensor obtains a maximum FoM of 265 and 366 per RIU for transverse polarization modes (x and y), respectively. Along with sensitivity and FoM, the resolution (R) of the designed sensor is evaluated to provide an in-depth assessment of its performance. The maximum resolutions of 6.25 × 10−6 and 5 × 10−6 RIU are observed for the transverse polarization modes (x and y), respectively.
| Analyte RI | Resonant wavelength (nm) | WS (nm per RIU) | AS (per RIU) | FoM (per RIU) | ||||
|---|---|---|---|---|---|---|---|---|
| x-pol | y-pol | x-pol | y-pol | x-pol | y-pol | x-pol | y-pol | |
| 1.33 | 700 | 700 | 2000 | 2000 | 219 | 247 | 66 | 68 |
| 1.34 | 720 | 720 | 3000 | 3000 | 265 | 278 | 97 | 99 |
| 1.35 | 750 | 750 | 3000 | 3000 | 322 | 346 | 92 | 97 |
| 1.36 | 780 | 780 | 3000 | 3000 | 354 | 429 | 87 | 92 |
| 1.37 | 810 | 810 | 4000 | 5000 | 445 | 508 | 109 | 142 |
| 1.38 | 850 | 860 | 6000 | 6000 | 526 | 615 | 144 | 155 |
| 1.39 | 910 | 920 | 7000 | 7000 | 594 | 688 | 149 | 152 |
| 1.4 | 980 | 990 | 10 000 |
12 000 |
658 | 836 | 197 | 215 |
| 1.41 | 1080 | 1110 | 16 000 |
20 000 |
653 | 1178 | 265 | 366 |
| 1.42 | 1240 | 1310 | ||||||
The efficacy of a sensor can be assessed by examining the linearity of the fitting curves. A strong association between RI changes and sensor response is reflected by an increased slope of the curve fitting. Fig. 3e and f illustrate the fluctuation in resonance wavelength and the corresponding fitting curves for analyte RI ranging from 1.33 to 1.42. The table displays the parameters and results for the fourth-order fitting.
The adjusted R2 values for the fitted curve of the resonance wavelengths are 0.99953 and 0.99907 for transverse polarization modes (x and y), respectively, very close to 1. This indicates that the designed sensor demonstrates exceptional sensing capabilities.
In all cases, a more defined peak profile with a greater confinement loss is achieved in the y-polarization mode. This indicates that the SPP mode operates more effectively, and the plasmonic resonance state is more prominent in y-polarization. Therefore, in subsequent investigations, we examine the sensor's y-polarization reliability.
Table 4 presents a comparative study of the designed D-shaped PCF-based SPR sensor's performance with existing published PCF-based SPR sensors, emphasizing the key characteristics such as AS, WS, R, and FoM. Our designed D-shaped sensor exhibits excellent performance compared to the other sensors, offering the maximum AS of 1178 per RIU, the highest WS of 20
000 nm per RIU, excellent wavelength resolution of 5 × 10−6 RIU, and a moderate FoM of 366 per RIU for y polarization mode. The aforementioned properties make the designed sensor exceptionally effective for accurate and precise RI detection.
| Configuration | RI range | Max. WS (nm per RIU) | Max. AS (per RIU) | R (RIU) | FoM (per RIU) | Ref. |
|---|---|---|---|---|---|---|
| Dual-channel D-shaped | 1.31–1.41 | 10 000 |
216 | 5 × 10−5 | 125 | 36 |
| D-shaped | 1.35–1.46 | 5600 | — | 8 × 10−4 | — | 37 |
| D-shaped | 1.26–1.38 | 5400 | — | — | — | 38 |
| Hoop-cut | 1.39–1.44 | 2000 | 374.062 | 39 | ||
| Proposed structure | 1.33–1.42 | 20 000 |
1178 | 5 × 10−6 | 366 |
![]() | ||
| Fig. 4 Effect of the variation in air hole diameters d1 and d2 on the sensor's (a and c) confinement loss, and (b and d) AS for analyte RI varying from 1.40 to 1.41, respectively. | ||
| Diameter (µm) | Wlpeak (µm), na = 1.40 | Wlpeak (µm), na = 1.41 | Confinement loss (dB cm−1), na = 1.40 | Confinement loss (dB cm−1), na = 1.41 | AS (per RIU), na = 1.40 | AS (per RIU), na = 1.41 |
|---|---|---|---|---|---|---|
| d1 | ||||||
| 1.1 | 0.99 | 1.11 | 106.88 | 135.83 | 836 | 1178 |
| 1.3 | 0.99 | 1.11 | 114.95 | 151.69 | 862 | 971 |
| 1.5 | 0.99 | 1.11 | 122.12 | 166.71 | 885 | 1164 |
![]() |
||||||
| d2 | ||||||
| 3.5 | 0.99 | 1.11 | 105.41 | 139.10 | 795 | 977 |
| 3 | 0.99 | 1.11 | 106.88 | 135.83 | 836 | 1178 |
| 2.5 | 0.99 | 1.1 | 107.06 | 130.99 | 824 | 977 |
![]() |
||||||
| r | ||||||
| 8 | 0.99 | 1.11 | 106.88 | 135.83 | 836 | 1178 |
| 7 | 0.98 | 1.09 | 88.59 | 114.80 | 838 | 958 |
| 6 | 0.97 | 1.07 | 74.79 | 93.42 | 826 | 913 |
![]() |
||||||
| Pitch (µm) | ||||||
| 3.8 | 1.00 | 1.11 | 141.45 | 182.23 | 842 | 875 |
| 4.0 | 0.99 | 1.11 | 106.88 | 135.83 | 836 | 1178 |
| 4.2 | 0.99 | 1.10 | 84.98 | 105.51 | 808 | 848 |
Simulations were carried out for d2 = 3.5, 3, 2.5 µm, with the outcomes displayed in Fig. 4c and d and Table 5. Fig. 4c shows that the peak loss for analyte RIs lies within the range of 1.40 to 1.41. The study indicates that the loss peak decreases as d2 increases, and the loss peak exhibits an upward shift as d2 decreases. The phenomenon occurs because of a bigger air hole diameter, which effectively confines the core-directed mode, keeping more of the light within the core and reducing interaction with the plasmonic film. As a result, the excitation of surface electrons weakens, lowering the evanescent wave's penetration and the overall confinement loss. A red shift is also observed with the increase in hole size. Fig. 4d presents the AS for na = 1.40 to na = 1.41. The overall best results were achieved at d2 = 3 µm.
![]() | ||
| Fig. 5 Effect of the variation in microchannel diameter r and pitch distance on the sensor's (a and c) confinement loss, and (b and d) AS for analyte RI varying from 1.40 to 1.41, respectively. | ||
![]() | ||
| Fig. 6 Impact of the variation in Au and TiO2 layer thickness on the sensor's (a and c) confinement loss, and (b and d) AS for analyte RI varying from 1.40 to 1.41, respectively. | ||
| Material thickness (nm) | Wlpeak (µm), na = 1.40 | Wlpeak (µm), na = 1.41 | Confinement loss (dB cm−1), na = 1.40 | Confinement loss (dB cm−1), na = 1.41 | AS (per RIU), na = 1.40 | AS (per RIU), na = 1.41 |
|---|---|---|---|---|---|---|
| Au | ||||||
| 60 | 1.0 | 1.11 | 70.33 | 85.68 | 613 | 649 |
| 55 | 0.99 | 1.11 | 106.89 | 135.83 | 836 | 1178 |
| 50 | 0.99 | 1.10 | 173.75 | 274.77 | 1405 | 1100 |
![]() |
||||||
| TiO2 | ||||||
| 10 | 1.02 | 1.13 | 110.60 | 141.70 | 798 | 1243 |
| 9 | 0.99 | 1.11 | 106.87 | 135.83 | 836 | 1178 |
| 8 | 0.97 | 1.08 | 104.43 | 133.22 | 852 | 1050 |
000 nm per RIU. Fig. 6d indicates that the AS achieves its highest value of 1243 per RIU at a TiO2 height of 10 nm, although its WS is comparatively lower than that of the 9 nm layer. The 9 nm TiO2 layer exhibits an optimal trade-off between confinement loss and sensitivity enhancement, exhibiting both superior WS and AS with moderate confinement loss. Therefore, a TiO2 layer height of 9 nm is identified as the efficient design parameter for the designed sensor. In Table 6, the correlation between the height of the TiO2 layer and the associated sensing performance is summarized in detail.
000 nm per RIU, 987 per RIU, and 220 per RIU at na = 1.41, respectively. Although this shows moderate sensitivity, adding an overlayer further improved performance. The overlayer optimizes resonance by enhancing the connection between SPP and core guided modes, increasing sensitivity. After adding a TiO2 overlayer, the sensor achieved the ultimate WS, AS, and FoM of 20
000 nm per RIU, 1178 per RIU, and 366 per RIU at na = 1.41, respectively. This underscores the importance of overlayers in refining the sensor's optical characteristics for better detection efficiency and sensitivity.
![]() | ||
| Fig. 7 Dispersion profile of (a) confinement loss and (b) AS for analyte RI varied from 1.40 to 1.41, when the simulation uses only an Au layer and with a TiO2 overlayer. | ||
| Analyte RI | WS (nm per RIU) | AS (per RIU) | FoM (per RIU) | |||
|---|---|---|---|---|---|---|
| Au | Au + TiO2 | Au | Au + TiO2 | Au | Au + TiO2 | |
| 1.33 | 2000 | 2000 | 100 | 247 | 50 | 68 |
| 1.34 | 1000 | 3000 | 132 | 278 | 26 | 99 |
| 1.35 | 2000 | 3000 | 172 | 346 | 54 | 97 |
| 1.36 | 2000 | 3000 | 240 | 429 | 56 | 92 |
| 1.37 | 3000 | 5000 | 324 | 508 | 84 | 142 |
| 1.38 | 4000 | 6000 | 431 | 616 | 110 | 155 |
| 1.39 | 5000 | 7000 | 593 | 689 | 128 | 152 |
| 1.4 | 8000 | 12 000 |
758 | 836 | 179 | 215 |
| 1.41 | 12 000 |
20 000 |
987 | 1178 | 220 | 366 |
| 1.42 | ||||||
![]() | ||
| Fig. 8 Fabrication tolerance investigation for ±2% deviation of (a) pitch (Λ), (b) Au layer thickness (tau), (c) diameter of air hole (d1), and (d) diameter of air hole (d2). | ||
Despite the promising numerical performance, especially the sensitivity of the proposed sensor, certain limitations should be acknowledged. This study does not consider the effects of other practical factors, such as temperature variations, measurement noise, and spectral broadening, which are not included in the simulations. These aspects can be evaluated in future work.
| Cell name | Cell type and concentration level | RI | Ref. | |
|---|---|---|---|---|
| Healthy cell | Cancerous cell | |||
| Basal cell | (30–70%) Non-malignant cell | 1.360 | 1.380 | 45 and 46 |
| (80%) Malignant skin lesion | ||||
| HeLa | (30–70%) Non-malignant cell | 1.368 | 1.392 | 45 and 46 |
| (80%) Cervical carcinoma | ||||
| Jurkat | (30–70%) Non-malignant cell | 1.376 | 1.390 | 45 and 46 |
| (80%) Blood malignancy | ||||
| PC12 | (30–70%) Non-malignant cell | 1.381 | 1.395 | 46 and 47 |
| (80%) Adrenal carcinoma | ||||
| MDA-MB-231 | (30–70%) Non-malignant cell | 1.385 | 1.399 | 46 and 47 |
| (80%) Mammary carcinoma | ||||
| MCF-7 | (30–70%) Non-malignant cell | 1.387 | 1.401 | 46 and 47 |
| (80%) Mammary carcinoma | ||||
In every scenario, carcinoma cells show higher confinement losses and redshifted resonance peaks in comparison to their normal counterparts. One of the most frequently employed means for assessing sensor efficacy is spectral interrogation, which is based on the variations in resonance peaks across the wavelength spectrum. This idea can be clarified by applying eqn (5), which examines wavelength changes associated with the loss peak and refractive index variations. Additionally, sensor effectiveness can be evaluated using the AS at a particular wavelength, as calculated using eqn (6). Based on the cancer cell types that were studied, the spectral sensitivities were 4000, 5000, 5714.29, 6428.57, 6428.57, and 7142.86 nm per RIU for Basal, HeLa, Jurkat, PC12, MDA-MB-231, and MCF-7 cells, while the corresponding ASs were 580.15, 628.57, 640.34, 669.29, 717.29, and 708.02 per RIU, respectively. Fig. 11 and Table 9 provide detailed information regarding the sensor's performance, including sensitivity, figure of merit (FoM), and resolution for six different types of carcinoma cells. The designed D-shaped sensor exhibits remarkable sensitivity, FoM, and resolution, signifying that this sensor delivers superior response. Moreover, in this study cancer cells detection are based on FEM simulations; experimental validation is the necessary next step to confirm the sensor's performance in real-world sample detection.
![]() | ||
| Fig. 11 AS for the following six carcinoma cell types: PC12, MDA-MB-231, Jurkat, HeLa, Basal, and MCF-7. | ||
| Cancer type | Cell type | WS (nm per RIU) | AS (per RIU) | FoM (per RIU) | Resolution (RIU) |
|---|---|---|---|---|---|
| Skin | Basal | 4000.00 | 580.15 | 122.70 | 2.5 × 10−5 |
| Cervical | HeLa | 5000.00 | 628.57 | 144.93 | 2.0 × 10−5 |
| Blood | Jurkat | 5714.29 | 640.34 | 155.28 | 1.75 × 10−5 |
| Adrenal gland | PC12 | 6428.57 | 669.29 | 159.91 | 1.56 × 10−5 |
| Breast | MDA-MB-231 | 6428.57 | 717.29 | 153.06 | 1.56 × 10−5 |
| Breast | MCF-7 | 7142.86 | 708.02 | 165.34 | 1.40 × 10−5 |
000 nm per RIU across the RI span of 1.330 to 1.420 for y-polarized light. The sensor also depicted outstanding FoM, AS, and resolution values of 366 per RIU, 1178 per RIU, and 5 × 10−6 RIU, respectively, within the aforementioned RI range. Finally, a convenient and effective way of the presented sensor's fabrication is proposed with a detailed analysis of fabrication feasibility via investigating its fabrication tolerance. The outcomes of the simulation show an impressive improvement in sensitivity and accuracy compared to the state-of-the-art studies in the literature, which is a testament that the designed architecture could be an effective tool for the precise diagnosis of cancer with better resolution. It should be emphasized that all analyses, including cancer-cell detection and fabrication-tolerance evaluation, are carried out through FEM simulations; experimental validation is required to confirm the sensor's performance in real biological environments.
| This journal is © The Royal Society of Chemistry 2026 |